SOLARA — Solara Active Pharma Sciences Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Solara Active Pharma Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	16,169	12,683	14,438	12,889	12,838
Cost of Revenue
Gross Profit	8,084	5,223	5,491	3,301	6,574
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	13,323	12,978	14,162	16,766	11,767
Operating Profit	2,846	-295	276	-3,877	1,070
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,215	-911	-448	-4,884	5.4
Provision for Income Taxes
Net Income After Taxes	2,214	-583	-223	-5,670	5.4
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,214	-582	-222	-5,674	5.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,214	-582	-222	-5,674	5.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	58.9	-14.2	-5.6	-114	0.14
Dividends per Share